Public Company News

Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets)

Bringing New Hope to Chinese Dialysis Patients with Hyperphosphatemia SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma; stock code: 600196.SH, 02196.HK) announced that its holding subsidiary, Shanghai Fosun Pharmaceutical Industrial Development...

2025-02-26 18:33 2411

Ping An Health Launches "Ping An Xin Yi" AI Doctor Assistant Service to Enhance Accessibility and Satisfaction in Medical Services

HONG KONG and SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently announced the launch of "Ping An Xin Yi ," an AI-powered digital doctor service integrated within its Pi...

2025-02-26 17:06 2506

US SMEs prioritise trendy and high-quality products as direct sourcing takes centre stage, reveals new Alibaba.com research

As 44% of US SMEs plan to find new suppliers, driving cost efficiency and enhancing product quality amongst top priorities for year ahead NEW YORK, Feb. 26, 2025 /PRNewswire/ -- Small and medium-sized enterprises (SMEs) across theUSA are set to make major changes to their product sourcing strate...

2025-02-26 17:00 3470

FinVolution's Philippine Subsidiary Partners with Security Bank to Drive Financial Inclusion

SHANGHAI, Feb. 26, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced that its Philippine financial application, JuanHand, has entered into a credit facility agreement with Security Bank Corporation (Security Bank), o...

2025-02-26 17:00 3419

Waterdrop Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 12, 2025

BEIJING, Feb. 26, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH ) ("Waterdrop" or the "Company"), a leading technology platform d...

2025-02-26 16:30 3161

Gaotu Techedu Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

BEIJING, Feb. 26, 2025 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a technology-driven education company and online large-class tutoring service provider inChina, today announced its unaudited financial results for the fourth quarter and fiscal year endedDecember 3...

2025-02-26 14:00 2590

Tuniu to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 14, 2025

NANJING, China, Feb. 26, 2025 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2024, before...

2025-02-26 14:00 1934

Jolywood Unveils Breakthrough Windproof Module and Full-Black Solar Technology at Intersolar North America 2025

SAN DIEGO, Feb. 25, 2025 /PRNewswire/ -- Jolywood, a leading innovator in advanced solar technologies, is proud to unveil its latest advancements at Intersolar North America 2025, held at the San Diego Convention Center.  As a pioneer in N-type solar technology, Jolywood continues to push the bou...

2025-02-26 11:58 2331

HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , Feb. 25, 2025 /PRNewswire/ -- HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaboration and license agreement with a business partner to advance ...

2025-02-26 08:03 2179

GoldenHome Dazzles at KBIS 2025 with Innovative Custom Cabinetry and Closet Solutions

LAS VEGAS, Feb. 25, 2025 /PRNewswire/ -- GoldenHome, a global leader in custom home solutions, is showcasing its latest collection of cabinets and closets featuring smart and contemporary design aesthetics at the 2025 Kitchen and Bath Industry Show (KBIS) inLas Vegas. This year marks GoldenHome's...

2025-02-26 02:00 2049

Eason Technology Securres HK $1.5 Million in Funding to Accelerate Blockchain Intellectual Property Protection Development

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Eason Technology Limited ("Eason" or the "Company") (NYSE American: DXF), a company engaged in real estate operation management and investment, and digital technology security business, today announced a transaction in which Renying Capital have invested H...

2025-02-25 22:40 3113

Gaudio Lab Returns to SXSW with an Immersive "Audio-Driven Campsite" Experience

AUSTIN, Texas, Feb. 25, 2025 /PRNewswire/ -- Gaudio Lab, a leading innovator in AI-powered audio and spatial sound technology, will return to SXSW 2025, unveiling an immersive "audio-driven campsite" experience. This marks the company's second consecutive year at SXSW, reinforcing its position as...

2025-02-25 22:00 2295

SunCar Technology Addresses National Automotive Circulation Industry Forum, Showcasing Digital Solutions for Dealers

NEW YORK, Feb. 25, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services inChina, participated in the National Automotive Circulation Industry New Year Forum and Consumer Promotion Co...

2025-02-25 21:45 2888

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

* SK bioscience's first mRNA vaccine candidate enters Phase 1/2 clinical trials inAustralia and New Zealand, with interim results expected by 2026 * Joint R&D project between SK and CEPI includes up to USD 40 million in initial funding support from CEPI * SK bioscience will expand its vaccin...

2025-02-25 21:00 2701

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

SHANGHAI, Feb. 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK, "CARsgen Therapeutics"), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces reaching agreements with an investment fund m...

2025-02-25 21:00 2509

RoboSense Achieves Milestone with Production and Delivery of Its 1 Millionth LiDAR

SHENZHEN, China, Feb. 25, 2025 /PRNewswire/ -- On February 21, RoboSense (2498.HK), an AI-driven robotics technology company that supplies industry-leading incremental components and solutions for the robotics market, held a ceremony inShenzhen to celebrate the production of its 1 millionth LiDAR...

2025-02-25 20:34 3488

Euro Tech Holdings Company Limited Reports Contracts Awarded to PACT

HONG KONG, Feb. 25, 2025 /PRNewswire/ -- Euro Tech Holdings Company Limited (Nasdaq: CLWT) today announced that its majority-owned subsidiary, YixingPACT Environmental Technology Company Ltd. ("PACT") has recently been awarded two contracts worth approximatelyUS$2.2 million in total. One project ...

2025-02-25 20:00 2227

Baidu Acquires JOYY's Live Streaming Business in China

BEIJING, Feb. 25, 2025 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) ("Baidu"), a leading AI company with strong Internet foundation, today announced that Baidu entered into agreements with JOYY Inc and acquired the video-based entertainment live ...

2025-02-25 19:00 2487

China Yuchai International Announces Unaudited 2024 Second Half-Year and Full Year Financial Results

SINGAPORE, Feb. 25, 2025 /PRNewswire/ -- China Yuchai International Limited  (NYSE: CYD) ("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce to...

2025-02-25 19:00 3635

MicuRx Pharmaceutical: Contezolid Global Phase III Clinical Trial Safety and Efficacy Evaluation Endorsed by Data Monitoring Committee, Promising Prospects for Diabetic Foot Infection Treatment

* Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued progression as planned  * MRX-4 Injection followed by Contezolid Tablets demonstrated favorable safety and efficacy profiles in patients with...

2025-02-25 18:44 1736
1 ... 130131132133134135136 ... 778